ELIZABETH MCGRATH: Open Payments
NPI 1477764363 · BARRINGTON, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,856 in 76 payments from 18 companies in 2025. Trend: 2023 $1,413 · 2024 $1,240 · 2025 $1,856
Food & beverage: $1,856
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 13 | $352 |
| ABBVIE INC. | 12 | $255 |
| AstraZeneca Pharmaceuticals LP | 8 | $225 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $189 |
| Abbott Laboratories | 5 | $112 |
| Novo Nordisk Inc | 4 | $104 |
| Lundbeck LLC | 5 | $102 |
| Lilly USA, LLC | 3 | $81 |
| GlaxoSmithKline, LLC. | 4 | $79 |
| Sumitomo Pharma America, Inc. | 3 | $70 |
Products named: CAPLYTA, BREZTRI, VRAYLAR, ELIQUIS, FREESTYLE LIBRE 3, REXULTI, ABRYSVO, Wegovy.
Industry payments across RI — which companies pay providers there.
